Project Bacchus was a covert investigation by the Defense Threat Reduction Agency US Defense Department to determine whether it is possible to construct a bioweapons production facility with off-the-shelf equipment.
History[edit | edit source]
The operation[edit | edit source]
Project Bacchus ran during 1999 and 2000 and investigated whether would-be terrorists could build an anthrax production facility and remain undetected. In the two-year simulation, the facility was constructed, and production of an anthrax-like bacterium was successfully achieved. The participating scientists were able to produce about one kilogram of highly refined bacterial particles.
Reportage[edit | edit source]
The secret Project Bacchus was revealed to the public in a September 2001 article in The New York Times. Reporters Judith Miller, Stephen Engelberg and William J. Broad collaborated to write the article. It is presumed that the reporters had knowledge of the program for at least several months; shortly after the article appeared they published a book that detailed the story further. The book, Germs: Biological Weapons and America's Secret War, and the article are the only publicly available sources concerning Project Bacchus and its sister projects, Clear Vision and Jefferson.
References[edit | edit source]
Further reading[edit | edit source]
- Tucker, Jonathan B. "Biological Threat Assessment: Is the Cure Worse Than the Disease?", Arms Control Today, October 2004, accessed January 6, 2009.
- Miller, Judith, Engelberg, Stephen and Broad, William J. Germs: Biological Weapons and America's Secret War, (Google Books), Simon & Schuster, 2002, (ISBN 0684871599).
- -- "U.S. Germ Warfare Research Pushes Treaty Limits", The New York Times, September 4, 2001, accessed January 6, 2009.
|This page uses Creative Commons Licensed content from Wikipedia (view authors).|